biomedicina slovenica


"FILGRASTIM" : 9

  1. Skopec Barbara; Škerget Matevž; Žontar Darja; Zadnik Vesna; Zver Samo
    Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients
    2017
  2. Mlakar Uroš
    Indikacije za zdravljenje z eritropoetinom
    [Indications for treatment with erythropoietin]
    2005
  3. Molnar-Novak Helena; Bedernjak-Bajuk Nataša
    Agranulocitoza in hepatitis po metimazolu pri bolnici z bazedovko, ki je nastala po terapiji z radiojodom
    [Methimazole induced agranulocitosis and hepatitis in patient with Graves disease appeared after radioiodine treatment]
    2004
  4. Therasse P; Mauriac L; Welnicka-Jaskiewicz M; Bruning P; Čufer T; Bonnefoi H; Tomiak E; Pritchard KI; Hamilton A; Piccart MJ
    Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study
    2003
  5. Černelč Peter; Andoljšek Dušan; Mlakar Uroš; Pretnar Jože; Modic Mojca; Zupan Irena P; Zver Samo
    Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis
    2000
  6. Lavrič A; Tibaut D; Nemec M; Štalc A
    Biological parameters in wistar rats after long-term treatment of filgrastime (BIOFA)
    1999
  7. Černelč Peter; Andoljšek Dušan; Mlakar Uroš; Modic Mojca; Pretnar Jože; Zver Samo; Zupan Irena
    Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis
    1999
  8. Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Tomiak E; Curran D; Ramirez A; Koopmanschap M; Piccart M
    An EORTC-NCIC-SAKK neoadjuvant randomized phase III study comparing CEF (5FU, epirubicin, cyclophosphamide) vs dose intensified EC+G-CSF (filgrastim) in locally advanced breast cancer (LABC): updated results including quality of life
    1998
  9. Therasse P; Mauriac L; Welincka M; Bruning P; Čufer T; Bonnefoi H; Tomiak E; Hamilton A; Piccart M
    Neo-adjuvant dose intensive chemotherapy in locally advanced breast cancer (LABC): an EORTC-NCIC-SAKK randomized phase 3 study comparing FEC (5FU, epirubicin, cyclophosphamide) VS high dose intensity EC + G-CSF (filgrastim)
    1998



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics